Australia markets open in 1 hour 18 minutes

Yantai Zhenghai Biotechnology Co., Ltd. (300653.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
23.61+0.62 (+2.70%)
At close: 03:04PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 4.25B
Enterprise value 3.55B
Trailing P/E 24.09
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)10.87
Price/book (mrq)4.30
Enterprise value/revenue 9.00
Enterprise value/EBITDA 16.67

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-48.73%
S&P500 52-week change 323.10%
52-week high 348.13
52-week low 318.11
50-day moving average 323.58
200-day moving average 328.16

Share statistics

Avg vol (3-month) 32.55M
Avg vol (10-day) 32.76M
Shares outstanding 5180M
Implied shares outstanding 6182.34M
Float 8103.45M
% held by insiders 144.31%
% held by institutions 19.24%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.6
Forward annual dividend yield 42.54%
Trailing annual dividend rate 30.80
Trailing annual dividend yield 33.48%
5-year average dividend yield 41.22
Payout ratio 461.22%
Dividend date 3N/A
Ex-dividend date 430 May 2023
Last split factor 21.5:1
Last split date 319 May 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 45.14%
Operating margin (ttm)47.48%

Management effectiveness

Return on assets (ttm)10.69%
Return on equity (ttm)18.66%

Income statement

Revenue (ttm)394.21M
Revenue per share (ttm)2.17
Quarterly revenue growth (yoy)-17.80%
Gross profit (ttm)N/A
EBITDA 199.7M
Net income avi to common (ttm)177.94M
Diluted EPS (ttm)0.98
Quarterly earnings growth (yoy)-24.40%

Balance sheet

Total cash (mrq)702.91M
Total cash per share (mrq)3.83
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)10.53
Book value per share (mrq)5.39

Cash flow statement

Operating cash flow (ttm)165.48M
Levered free cash flow (ttm)86.13M